Comparison 9. Patient reports/series: number of participants with serious adverse events.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Central nervous system | Other data | No numeric data | ||
1.1 Psychotic conditions | Other data | No numeric data | ||
1.2 Seizures | Other data | No numeric data | ||
1.3 Cerebral arteritis | Other data | No numeric data | ||
1.4 Self‐harm and suicidal behaviour | Other data | No numeric data | ||
1.5 Death | Other data | No numeric data | ||
1.6 Dyskinesia | Other data | No numeric data | ||
2 Cardiovascular and respiratory system | Other data | No numeric data | ||
2.1 Cardiovascular events | Other data | No numeric data | ||
2.2 Hypertension | Other data | No numeric data | ||
3 Gastrointestinal system: hepatoxicity | Other data | No numeric data | ||
4 Urogenital system: priapism | Other data | No numeric data |